We are live on ! Find out more
KURA icon

Kura Oncology
KURA

134 hedge funds and large institutions have $856M invested in Kura Oncology in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

373% more call options, than puts

Call options by funds: $4.07M | Put options by funds: $859K

103% more capital invested

Capital invested by funds: $421M → $856M (+$435M)

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

66% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 35

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

13% more funds holding

Funds holding: 119 → 134 (+15)

2.74% more ownership

Funds ownership: 93.43% → 96.16% (+2.7%)

Holders
134
Holders Change
+15
Holders Change %
+12.61%
% of All Funds
2.75%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
31
Increased
58
Reduced
35
Closed
16
Calls
$4.07M
Puts
$859K
Net Calls
+$3.21M
Net Calls Change
+$3.32M

Top Buyers

1
BlackRock
BlackRock
New York
+$20M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.3M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$18.2M
4
FCMI
Foresite Capital Management IV
California
+$17.5M
5
EC
EcoR1 Capital
California
+$15.8M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$46.1M
2
PM
Prosight Management
Texas
-$11M
3
Brown Advisory
Brown Advisory
Maryland
-$6.25M
4
Millennium Management
Millennium Management
New York
-$4.56M
5
IC
Ikarian Capital
Texas
-$4.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$9.42M +$2.57M +178,000 +45%
VA
27
VR Adviser
New York
$9.37M +$8.29M +575,000 New
SFM
28
Sphera Funds Management
Israel
$8.71M +$7.71M +534,494 New
IC
29
Ikarian Capital
Texas
$7.59M -$4.24M -294,184 -39%
Charles Schwab
30
Charles Schwab
California
$5.37M +$1.11M +76,668 +30%
Axa
31
Axa
France
$5.13M -$161K -11,184 -3%
DCM
32
DAFNA Capital Management
California
$4.8M -$192K -13,281 -4%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$4.29M +$1.29M +89,617 +52%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$4.06M +$102K +7,100 +3%
CS
35
Candriam SCA
Luxembourg
$3.91M +$3.46M +239,704 New
ACM
36
Alethea Capital Management
Washington
$3.52M -$1.48M -102,821 -32%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.37M +$823K +57,065 +38%
AVM
38
Arch Venture Management
Illinois
$3.36M -$2.88M -200,000 -49%
Point72 Asset Management
39
Point72 Asset Management
Connecticut
$2.9M +$2.57M +178,100 New
EAM
40
Erste Asset Management
Austria
$2.85M – – –
Millennium Management
41
Millennium Management
New York
$2.69M -$4.56M -315,861 -66%
Aviva
42
Aviva
United Kingdom
$2.35M -$1.51M -104,525 -42%
Two Sigma Investments
43
Two Sigma Investments
New York
$2.18M -$465K -32,258 -19%
WCM Investment Management
44
WCM Investment Management
California
$2.13M -$1.5M -103,662 -44%
State of New Jersey Common Pension Fund D
45
State of New Jersey Common Pension Fund D
New Jersey
$2M +$1.77M +122,828 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$1.91M +$589K +40,860 +53%
AGA
47
Altrinsic Global Advisors
Connecticut
$1.79M – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.78M +$629K +43,600 +66%
KCM
49
Kennedy Capital Management
Missouri
$1.64M -$64.6K -4,476 -4%
Bank of America
50
Bank of America
North Carolina
$1.45M +$94K +6,517 +8%
1
2
3 4 5

KURA Hedge Fund Activity: Q2 2020 in Review

134 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2020, worth a combined $856M — up 103% from $421M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new KURA positions and 16 closed out — a net gain of 15 holders — while 58 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $20M. The largest seller was Victory Capital Management, cutting an estimated $46.1M.

  • 134 institutional investors held Kura Oncology (KURA) as of Q2 2020, up from 119 in Q1 2020.
  • Funds reported $856M of Kura Oncology stock for Q2 2020, up 103% quarter-over-quarter.
  • 31 funds opened new Kura Oncology positions in Q2 2020 and 16 closed out, a net change of +15 holders.
  • The largest Kura Oncology buyer in Q2 2020 was BlackRock, an estimated $20M added.
  • The largest Kura Oncology seller in Q2 2020 was Victory Capital Management, an estimated $46.1M sold.

Based on aggregated 13F filings for Q2 2020.